Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,285
datasets available to search
ShareScore release 0.9.0
Dataset results
2,285 results for “T-cells”
Bispecific T-Cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previously Treated Extensive-Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Can
ClinicalTrials.gov study NCT07328490. IPD Sharing: YES. Countries: 1. Publications: 0.
Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT for Severe SCD
ClinicalTrials.gov study NCT00228631. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
ClinicalTrials.gov study NCT02159495. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy
ClinicalTrials.gov study NCT05464719. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Leukemia and Lymphoma Society (LLS) T-cells in Blood Cancer and COVID-19
ClinicalTrials.gov study NCT04898985. IPD Sharing: NO. Countries: 1. Publications: 0.
CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia
ClinicalTrials.gov study NCT05043571. IPD Sharing: NO. Countries: 1. Publications: 0.
Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma
ClinicalTrials.gov study NCT06160843. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases
ClinicalTrials.gov study NCT07155369. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Chidamide Combined With BEAM Pretreatment Regimen in Autologous Transplantation for T-cell Lymphoma
ClinicalTrials.gov study NCT05367856. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT05326243. IPD Sharing: NO. Countries: 1. Publications: 0.
RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00081874. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SHR2554 as Maintenance Therapy in Patients With Peripheral T-cell Lymphoma
ClinicalTrials.gov study NCT07347288. IPD Sharing: YES. Countries: 1. Publications: 0.
T-cell Dysfunction in Chronic HBV Infection
ClinicalTrials.gov study NCT05099458. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CAR-Multicenter Analysis (CAR-MA): Retrospective Study to Characterize CAR T-cell Outcomes and Related Toxicities in Children and Young Adults With B-ALL
ClinicalTrials.gov study NCT05440409. IPD Sharing: YES. Countries: 1. Publications: 0.
Vorinostat With or Without Bortezomib in Treating Patients With Refractory or Recurrent Stage IIB, Stage III, or Stage IV Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT01386398. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Bispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients
ClinicalTrials.gov study NCT06505369. IPD Sharing: Not stated. Countries: 3. Publications: 0.
UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus
ClinicalTrials.gov study NCT06920433. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alpha/Beta T-cell Depleted Blood-forming Stem Cell Transplant From Related or Unrelated Donors for Blood Diseases in Children and Young Adults
ClinicalTrials.gov study NCT04806347. IPD Sharing: NO. Countries: 0. Publications: 0.
Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
ClinicalTrials.gov study NCT04848064. IPD Sharing: NO. Countries: 1. Publications: 0.
Autologous Bedside CD19 CAR T-cell Therapy for B-ALL
ClinicalTrials.gov study NCT07277504. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.